Logo image of CTM

CASTELLUM INC (CTM) Stock Fundamental Analysis

NYSEARCA:CTM - NYSE Arca - US14838T2042 - Common Stock - Currency: USD

0.8372  -0.05 (-5.37%)

After market: 0.8449 +0.01 (+0.92%)

Fundamental Rating

2

Overall CTM gets a fundamental rating of 2 out of 10. We evaluated CTM against 82 industry peers in the IT Services industry. CTM may be in some trouble as it scores bad on both profitability and health. CTM is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CTM had negative earnings in the past year.
CTM had a positive operating cash flow in the past year.
CTM Yearly Net Income VS EBIT VS OCF VS FCFCTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -5M -10M -15M

1.2 Ratios

With a Return On Assets value of -33.09%, CTM is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
CTM has a Return On Equity of -79.36%. This is in the lower half of the industry: CTM underperforms 78.21% of its industry peers.
Industry RankSector Rank
ROA -33.09%
ROE -79.36%
ROIC N/A
ROA(3y)-43.17%
ROA(5y)N/A
ROE(3y)-91.11%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CTM Yearly ROA, ROE, ROICCTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 -20 -40 -60 -80 -100

1.3 Margins

The Gross Margin of CTM (41.13%) is better than 62.82% of its industry peers.
CTM's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for CTM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.76%
GM growth 5YN/A
CTM Yearly Profit, Operating, Gross MarginsCTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 20 -20 40

More info and screens

2

2. Health

2.1 Basic Checks

CTM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CTM has more shares outstanding
Compared to 1 year ago, CTM has a worse debt to assets ratio.
CTM Yearly Shares OutstandingCTM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 10M 20M 30M 40M
CTM Yearly Total Debt VS Total AssetsCTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

CTM has an Altman-Z score of 0.50. This is a bad value and indicates that CTM is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CTM (0.50) is worse than 78.21% of its industry peers.
CTM has a debt to FCF ratio of 4.35. This is a neutral value as CTM would need 4.35 years to pay back of all of its debts.
CTM has a Debt to FCF ratio of 4.35. This is comparable to the rest of the industry: CTM outperforms 52.56% of its industry peers.
A Debt/Equity ratio of 0.75 indicates that CTM is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.75, CTM is doing worse than 64.10% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 4.35
Altman-Z 0.5
ROIC/WACCN/A
WACC10.87%
CTM Yearly LT Debt VS Equity VS FCFCTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 5M 10M 15M

2.3 Liquidity

A Current Ratio of 1.11 indicates that CTM should not have too much problems paying its short term obligations.
CTM has a worse Current ratio (1.11) than 73.08% of its industry peers.
CTM has a Quick Ratio of 1.11. This is a normal value and indicates that CTM is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of CTM (1.11) is worse than 70.51% of its industry peers.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 1.11
CTM Yearly Current Assets VS Current LiabilitesCTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

3

3. Growth

3.1 Past

CTM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 62.53%, which is quite impressive.
The Revenue has been growing slightly by 3.12% in the past year.
Measured over the past years, CTM shows a very strong growth in Revenue. The Revenue has been growing by 50.25% on average per year.
EPS 1Y (TTM)62.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.95%
Revenue 1Y (TTM)3.12%
Revenue growth 3Y50.25%
Revenue growth 5YN/A
Sales Q2Q%-1.13%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y61.9%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year20.37%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CTM Yearly Revenue VS EstimatesCTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CTM Yearly EPS VS EstimatesCTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 -0.05 -0.1 -0.15 -0.2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CTM. In the last year negative earnings were reported.
Also next year CTM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CTM Price Earnings VS Forward Price EarningsCTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, CTM is valued a bit cheaper than 65.38% of the companies in the same industry.
Industry RankSector Rank
P/FCF 24.56
EV/EBITDA N/A
CTM Per share dataCTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CTM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CASTELLUM INC

NYSEARCA:CTM (2/21/2025, 8:11:15 PM)

After market: 0.8449 +0.01 (+0.92%)

0.8372

-0.05 (-5.37%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)11-11 2024-11-11/bmo
Earnings (Next)03-19 2025-03-19/bmo
Inst Owners9.25%
Inst Owner Change211.71%
Ins Owners23.64%
Ins Owner Change2.28%
Market Cap58.55M
Analysts80
Price TargetN/A
Short Float %1.51%
Short Ratio0.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.29
P/FCF 24.56
P/OCF 24.55
P/B 4.87
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.18
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)0.03
FCFY4.07%
OCF(TTM)0.03
OCFY4.07%
SpS0.65
BVpS0.17
TBVpS-0.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -33.09%
ROE -79.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 41.13%
FCFM 5.23%
ROA(3y)-43.17%
ROA(5y)N/A
ROE(3y)-91.11%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.76%
GM growth 5YN/A
F-Score5
Asset Turnover1.58
Health
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 4.35
Debt/EBITDA N/A
Cap/Depr 0.04%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.11
Quick Ratio 1.11
Altman-Z 0.5
F-Score5
WACC10.87%
ROIC/WACCN/A
Cap/Depr(3y)1.89%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.1%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)62.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.95%
EPS Next Y61.9%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.12%
Revenue growth 3Y50.25%
Revenue growth 5YN/A
Sales Q2Q%-1.13%
Revenue Next Year20.37%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y42.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year154.59%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-353.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-328.69%
OCF growth 3YN/A
OCF growth 5YN/A